HPRA Drug Safety Newsletter Edition 77
Download:
hpra-drug-safety-newsletter-edition-77.pdf
232 KB
The latest edition of the HPRA Drug Safety Newsletter (DSN) includes updates to support the safe and appropriate ise of the following medicines:
- Direct-Acting antivirals for hepatitis C : Advice on interaction potential with warfarin and other vitamin K antagonists.
- Advice on potential interaction between cobicistat-containing products and corticosteroids primarlily metabolised by CYP3A : Risk of adrenal suppression.
- Adverse reaction reporting during 2015.
« Back